DPHL: A DIA Pan-Human Protein Mass Spectrometry Library for Robust Biomarker DiscoveryTiansheng Zhu, Jiang Zhu, Syed Muhammad Fahmy Alkaff et al.|Genomics Proteomics & Bioinformatics|2020Cited by 99
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant dataLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|EClinicalMedicine|2022Cited by 76
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C. Knol, Connie R. Jiménez, Mengge Lyu et al.|Cancer Cell|2025Cited by 46
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|Cancers|2022Cited by 41
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|JAMA Network Open|2023Cited by 17